주식/증권 ➡️ 중립

XLV vs IBB: How Healthcare Diversification Compares to Biotech Concentration

Yahoo Finance 2026/09/24 16:03:56 34회

요약

XLV offers exposure to the broader healthcare sector, while IBB targets biotech innovators. Here's how the two stack up on risk, returns, and diversification.

원문 기사 보기

관련 뉴스

TNL Mediagene regains Nasdaq minimum bid price compliance

2026/10/16

Blue Origin eyes 50 annual New Glenn launches in $330M Cape Canaveral expansion

2026/10/16

Lilly wins EU backing for Foundayo weight-loss pill

2026/10/16

Jefferies technical analyst finds an encouraging development in Thursday rebound, setting stage for rally into year-end

2026/10/16

뉴스 목록으로